4basebio (LSE:4BB) Other Stockholders Equity: £14.68 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:4BB 4basebio PLC LSE:4BB
61 GF Score
Price £5.25
GF Value £28.47
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is 4basebio Other Stockholders Equity?

4basebio LSE:4BB 61 Other Stockholders Equity is £14.68 Mil as of Dec. 2025. GuruFocus rates LSE:4BB with a GF Score™ of 61/100 and a GF Value™ of £28.47 (Possible Value Trap). The stock has 7 warning signs investors should review.

4basebio's Other Stockholders Equity for the quarter that ended in Dec. 2025 was £14.68 Mil.

4basebio's quarterly Other Stockholders Equity increased from Dec. 2024 (£14.08 Mil) to Jun. 2025 (£14.47 Mil) and increased from Jun. 2025 (£14.47 Mil) to Dec. 2025 (£14.68 Mil).

4basebio's annual Other Stockholders Equity increased from Dec. 2023 (£14.06 Mil) to Dec. 2024 (£14.08 Mil) and increased from Dec. 2024 (£14.08 Mil) to Dec. 2025 (£14.68 Mil).

4basebio Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for 4basebio's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4basebio Other Stockholders Equity Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 13.43 14.01 14.06 14.08 14.68

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.06 14.32 14.08 14.47 14.68
LSE:4BB
61GF Score
4basebio PLC LSE:4BB
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4basebio Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of £14.68 Mil mean?
4basebio (LSE:4BB) has a Other Stockholders Equity of £14.68 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on 4basebio and its competitors.
Is 4basebio's Other Stockholders Equity too high?
4basebio's current Other Stockholders Equity is £14.68 Mil. Overall, 4basebio has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 4basebio's Other Stockholders Equity compare to VRTX and REGN?
4basebio's Other Stockholders Equity of £14.68 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on 4basebio and its competitors. 4basebio's current Other Stockholders Equity is £14.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4basebio stock overvalued right now?
Based on GuruFocus' analysis, 4basebio (LSE:4BB) is currently considered Possible Value Trap. The stock's GF Value™ is £28.47, compared to a current price of £5.25 — trading 81.6% below its estimated fair value. The current Other Stockholders Equity is £14.68 Mil. 4basebio's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For 4basebio (LSE:4BB), the current Other Stockholders Equity is £14.68 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 4basebio (LSE:4BB) Overvalued in 2026?

Based on GuruFocus' analysis, 4basebio stock appears to be undervalued. The current stock price of £5.25 is trading 81.6% below its estimated GF Value™ of £28.47. GuruFocus considers 4basebio to be Possible Value Trap.

Key valuation signals for LSE:4BB:

  • Other Stockholders Equity: £14.68 Mil
  • GF Value™: £28.47 vs. price of £5.25 (81.6% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the LSE:4BB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

4basebio Business Description

Other Exchanges 88Q:Germany
Address 25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effectively and safely delivering these DNA-based products to patients. The company operates across three geographic segments: Europe, the United States, and the Rest of the World, with the majority of its revenue generated from the United States.
61GF Score

Get the complete analysis for LSE:4BB

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£5.25
Price
£28.47
GF Value